Bachem Investor Relations Material
Latest events
H1 2025
Bachem
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Bachem Holding AG
Access all reports
Bachem Holding AG develops and manufactures peptides and oligonucleotides for the pharmaceutical and biotechnology industries. The company offers products and services for research, clinical development, and commercial-scale production of active pharmaceutical ingredients. It supports customers with custom synthesis and contract manufacturing. The company is headquartered in Bubendorf, Switzerland, and its shares are listed on the SIX.
Key slides for Bachem Holding AG
CMD 2024
Bachem Holding AG
H2 2024
Bachem Holding AG
Latest articles
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
Ticker symbol
BANB
Country
🇨🇭 Switzerland